Next Article in Journal
Isolation, Identification, and Characterization of an Unknown Impurity in Lovastatin EP
Previous Article in Journal
Preparation and Quality Control of the [153Sm]-Samarium Maltolate Complex as a Lanthanide Mobilization Product in Rats
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

In Vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation

University Institute of Pharmaceutical Sciences, Panjab University,160014,Chandigarh, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(1), 103-116; https://doi.org/10.3797/scipharm.0909-08
Submission received: 17 September 2009 / Accepted: 18 January 2010 / Published: 18 January 2010

Abstract

The aim of present investigation was 1) to evaluate the in vivo bioavailability of an Etodolac (ETD)-β-cyclodextrin (β-CD) inclusion complex system prepared by kneading and spray drying techniques in rats, 2) to study the pharmacodynamic parameters in various animal models for analyzing the therapeutic response and, 3) to evaluate the pharmacokinetic profile of the drug administered. Inclusion complexation with β-CD enhanced the solubility of the drug, improved bioavailability and reduced ulcerogenicity of ETD in rats. Pharmacodynamic studies were carried out in normal LACA mice and pharmacokinetic evaluation was done in male Wistar rats. Pharmacokinetic parameters evaluated for the inclusion complexes revealed good correlation. The minimum dose necessary to produce analgesic or anti-arthritic activity was also decreased, indicating that the host-guest strategy that uses β-CD and ETD was very effective and could be successfully employed in the preparation of pharmaceutical formulations of anti-arthritics and analgesics.
Keywords: ETD; β-Cyclodextrin; Inclusion-complexes; Bioavailability; Ulcerogenicity ETD; β-Cyclodextrin; Inclusion-complexes; Bioavailability; Ulcerogenicity

Share and Cite

MDPI and ACS Style

SINHA, V.R.; AMITA; GOEL, H. In Vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation. Sci. Pharm. 2010, 78, 103-116. https://doi.org/10.3797/scipharm.0909-08

AMA Style

SINHA VR, AMITA, GOEL H. In Vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation. Scientia Pharmaceutica. 2010; 78(1):103-116. https://doi.org/10.3797/scipharm.0909-08

Chicago/Turabian Style

SINHA, Vivek Ranjan, AMITA, and Honey GOEL. 2010. "In Vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation" Scientia Pharmaceutica 78, no. 1: 103-116. https://doi.org/10.3797/scipharm.0909-08

APA Style

SINHA, V. R., AMITA, & GOEL, H. (2010). In Vivo Bioavailability and Therapeutic Assessment of Host-Guest Inclusion Phenomena for the Hydrophobic Molecule Etodolac: Pharmacodynamic and Pharmacokinetic Evaluation. Scientia Pharmaceutica, 78(1), 103-116. https://doi.org/10.3797/scipharm.0909-08

Article Metrics

Back to TopTop